Meena Kanduri

A differentially methylated imprinting control region within the Kcnq1 locus harbors a methylation-sensitive chromatin insulator.

Multiple nucleosome positioning sites regulate the CTCF-mediated insulator function of the H19 imprinting control region.

The kinetics of deregulation of expression by de novo methylation of the h19 imprinting control region in cancer cells.

Bidirectional silencing and DNA methylation-sensitive methylation-spreading properties of the Kcnq1 imprinting control region map to the same regions.

The binding sites for the chromatin insulator protein CTCF map to DNA methylation-free domains genome-wide.

An antisense RNA regulates the bidirectional silencing property of the Kcnq1 imprinting control region.

The DNA binding activities of Smad2 and Smad3 are regulated by coactivator-mediated acetylation.

TP53 mutations predict for poor survival in de novo diffuse large B-cell lymphoma of germinal center subtype.

Rapamycin shows anticancer activity in primary chronic lymphocytic leukemia cells in vitro, as single agent and in drug combination.

In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosis.

Differential genome-wide array-based methylation profiles in prognostic subsets of chronic lymphocytic leukemia.

Distinct gene expression profiles in subsets of chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors.

TP53 Mutations are infrequent in newly diagnosed chronic lymphocytic leukemia.

Quantitative evaluation of p16(INK4a) promoter methylation using pyrosequencing in de novo diffuse large B-cell lymphoma.

LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia.

Presence of FLT3-ITD and high BAALC expression are independent prognostic markers in childhood acute myeloid leukemia.

Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia.

Screening for cytotoxic compounds in poor-prognostic chronic lymphocytic leukemia.

Distinct transcriptional control in major immunogenetic subsets of chronic lymphocytic leukemia exhibiting subset-biased global DNA methylation profiles.

ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia.

A key role for EZH2 in epigenetic silencing of HOX genes in mantle cell lymphoma.

microRNA-34b/c on chromosome 11q23 is aberrantly methylated in chronic lymphocytic leukemia.

The risk-associated long noncoding RNA NBAT-1 controls neuroblastoma progression by regulating cell proliferation and neuronal differentiation.

MCPH1 maintains long-term epigenetic silencing of ANGPT2 in chronic lymphocytic leukemia.

Epigenetic silencing of miR-26A1 in chronic lymphocytic leukemia and mantle cell lymphoma: Impact on EZH2 expression.

Global DNA methylation profiling reveals new insights into epigenetically deregulated protein coding and long noncoding RNAs in CLL.